Cargando…
Therapeutic strategies for critically ill patients with COVID-19
Since the 2019 novel coronavirus disease (COVID-19) outbreak originated from Wuhan, Hubei Province, China, at the end of 2019, it has become a clinical threat to the general population worldwide. Among people infected with the novel coronavirus (2019-nCoV), the intensive management of the critically...
Autores principales: | Li, Lei, Li, Ranran, Wu, Zhixiong, Yang, Xianghong, Zhao, Mingyan, Liu, Jiao, Chen, Dechang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7167303/ https://www.ncbi.nlm.nih.gov/pubmed/32307593 http://dx.doi.org/10.1186/s13613-020-00661-z |
Ejemplares similares
-
Management of critically ill patients with COVID-19 in ICU: statement from front-line intensive care experts in Wuhan, China
por: Shang, You, et al.
Publicado: (2020) -
Prevalence and impact of acute renal impairment on COVID-19: a systematic review and meta-analysis
por: Yang, Xianghong, et al.
Publicado: (2020) -
COVID‐19 associated EBV reactivation and effects of ganciclovir treatment
por: Meng, Mei, et al.
Publicado: (2022) -
Expert consensus on the glycemic management of critically ill patients
por: Wu, Zhixiong, et al.
Publicado: (2022) -
CRITICALLY ILL COVID-19 PATIENTS AND THERAPEUTIC ANTICOAGULATION WITH HEPARIN
por: Vu, Michael, et al.
Publicado: (2022)